Effect of metformin and metformin/linagliptin on gut microbiota in patients with prediabetes

Effect of metformin and metformin/linagliptin on gut microbiota in patients with prediabetes

Abstract Lifestyle modifications, metformin, and linagliptin reduce the incidence of type 2 diabetes (T2D) in people with prediabetes. The gut microbiota (GM) may enhance such interventions' efficacy. We determined the effect of linagliptin/metformin (LM) vs metformin (M) on GM composition and...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Yoscelina Estrella Martínez-López, Daniel Neri-Rosario, Diego Armando Esquivel-Hernández, Cristian Padron-Manrique, Aarón Vázquez-Jiménez, Jean Paul Sánchez-Castañeda, David Girón-Villalobos, Cristian Mendoza-Ortíz, María de Lourdes Reyes-Escogido, Maria Lola Evia-Viscarra, Alberto Aguilar-Garcia, Osbaldo Resendis-Antonio, Rodolfo Guardado-Mendoza
Fformat: Erthygl
Iaith:English
Cyhoeddwyd: Nature Portfolio 2024-04-01
Cyfres:Scientific Reports
Pynciau:
Gut microbiota
Metformin
Linagliptin/metformin
Insulin resistance
Pancreatic β-cell function
Mynediad Ar-lein:https://doi.org/10.1038/s41598-024-60081-y

Rhyngrwyd

https://doi.org/10.1038/s41598-024-60081-y

Eitemau Tebyg